Elypta
7 known investors
Elypta develops a metabolism-based liquid biopsy that measures the GAGome, a set of biomarkers of tumor metabolism, and applies machine learning to noninvasively detect cancer signatures. The company focuses on early cancer detection to reduce cancer mortality.
Investors · 7
In the news
Frequently asked questions
- What does Elypta do?
- Elypta develops a metabolism-based liquid biopsy that measures the GAGome, a set of biomarkers of tumor metabolism, and applies machine learning to noninvasively detect cancer signatures. The company focuses on early cancer detection to reduce cancer mortality.
- Who are Elypta's investors?
- Elypta's investors include Bonnier Capital, Chalmers Ventures AB, Industrifonden, Navigare Ventures, Nina Capital, Norrsken VC, Sciety.